T CELL RECONSTITUTION AFTER STEM CELL AUTOGRAFTING

干细胞自体移植后 T 细胞重建

基本信息

  • 批准号:
    6374275
  • 负责人:
  • 金额:
    $ 28.26万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-07-01 至 2004-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (Verbatim from Investigator's abstract): Background: The recovery of CD4 T cells after high-dose chemo/radiotherapy in adult patients with cancer or autoimmune diseases is very slow (years) and may result in only limited T cell repertoire. A similar problem exists in AIDS patients treated with highly active anti-retroviral therapy. With the ultimate goal of designing strategies to improve the T cell regeneration after T lymphocytopenia, here we propose to study the mechanism of the T cell regeneration. Hypothesis: We hypothesize that after T-lymphocytopenia a substantial number of regenerating T cells originate from hemopoietic progenitors in young individuals whereas only few, if any, T cells originate from hemopoietic progenitors in older individuals. Instead, in the older individuals, the vast majority of T cells originate from the expansion of preexisting T cells. Methods: This hypothesis will be tested in severely lymphocytopenic patients with autoimmune diseases who have received high-dose chemo/radiotherapy plus anti-thymocyte globulin followed by autologous transplantation of hemopoietic (CD34+) cells. An extremely limited number of T cell clones survive such transplant conditioning/ CD34+ cell purification. Therefore, it is relatively easy (easier and more informative than in patients with only moderate T lymphocytopenia) to track down the fate of the surviving T cell clones and to detect T cells newly generated from hemopoietic progenitors post-transplant, using the following techniques: spectratyping, sequencing of the T cell receptor genes within a single spectratyping band, and quantifying T cells that contain T cell receptor-rearrangement excision circles (TREC). Outcome: If the above hypothesis is true, the repertoire of T cells, that is severely limited within the first several months after transplant, will later diversify in young (less than 5-years-old) whereas it will stay severely limited in older (greater than 45-years-old) patients. Also, if the hypothesis is true, the number of TREC-containing T cells post-transplant will be significantly higher in the young compared to the older patients. This will give impetus for developing strategies to enable older patients to generate T cells from hemopoietic progenitors, e.g., using thymopoietic cytokines or thymus grafting.
描述:(逐字摘自研究者摘要):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAN STOREK其他文献

JAN STOREK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAN STOREK', 18)}}的其他基金

T CELL REGENERATION IN PRIMATES
灵长类动物 T 细胞再生
  • 批准号:
    6940136
  • 财政年份:
    2003
  • 资助金额:
    $ 28.26万
  • 项目类别:
Preclinical Testing of Interleukin-7 in Primates
Interleukin-7 在灵长类动物中的临床前测试
  • 批准号:
    6319291
  • 财政年份:
    2001
  • 资助金额:
    $ 28.26万
  • 项目类别:
Preclinical Testing of Interleukin-7 in Primates
Interleukin-7 在灵长类动物中的临床前测试
  • 批准号:
    6528196
  • 财政年份:
    2001
  • 资助金额:
    $ 28.26万
  • 项目类别:
Preclinical Testing of Interleukin-7 in Primates
Interleukin-7 在灵长类动物中的临床前测试
  • 批准号:
    6644818
  • 财政年份:
    2001
  • 资助金额:
    $ 28.26万
  • 项目类别:
T CELL RECONSTITUTION AFTER STEM CELL AUTOGRAFTING
干细胞自体移植后 T 细胞重建
  • 批准号:
    6017567
  • 财政年份:
    1999
  • 资助金额:
    $ 28.26万
  • 项目类别:
T CELL RECONSTITUTION AFTER STEM CELL AUTOGRAFTING
干细胞自体移植后 T 细胞重建
  • 批准号:
    6510906
  • 财政年份:
    1999
  • 资助金额:
    $ 28.26万
  • 项目类别:
T CELL RECONSTITUTION AFTER STEM CELL AUTOGRAFTING
干细胞自体移植后 T 细胞重建
  • 批准号:
    6170806
  • 财政年份:
    1999
  • 资助金额:
    $ 28.26万
  • 项目类别:
T CELL RECONSTITUTION AFTER STEM CELL AUTOGRAFTING
干细胞自体移植后 T 细胞重建
  • 批准号:
    6613452
  • 财政年份:
    1999
  • 资助金额:
    $ 28.26万
  • 项目类别:
B CELL TRANSFUSIONS FOR POSTBMT IMMUNE DEFICIENCY
B 细胞输注治疗 TBMT 后免疫缺陷
  • 批准号:
    2112477
  • 财政年份:
    1995
  • 资助金额:
    $ 28.26万
  • 项目类别:
B CELL TRANSFUSIONS FOR POSTBMT IMMUNE DEFICIENCY
B 细胞输注治疗 TBMT 后免疫缺陷
  • 批准号:
    2895387
  • 财政年份:
    1995
  • 资助金额:
    $ 28.26万
  • 项目类别:

相似海外基金

SIGNAL TRANSDUCTION VIA THE CD4 MOLECULE
通过 CD4 分子进行信号转导
  • 批准号:
    3455200
  • 财政年份:
    1989
  • 资助金额:
    $ 28.26万
  • 项目类别:
SIGNAL TRANSDUCTION VIA THE CD4 MOLECULE
通过 CD4 分子进行信号转导
  • 批准号:
    3455198
  • 财政年份:
    1989
  • 资助金额:
    $ 28.26万
  • 项目类别:
SIGNAL TRANSDUCTION VIA THE CD4 MOLECULE
通过 CD4 分子进行信号转导
  • 批准号:
    3455199
  • 财政年份:
    1989
  • 资助金额:
    $ 28.26万
  • 项目类别:
SIGNAL TRANSDUCTION VIA THE CD4 MOLECULE
通过 CD4 分子进行信号转导
  • 批准号:
    2064344
  • 财政年份:
    1989
  • 资助金额:
    $ 28.26万
  • 项目类别:
SIGNAL TRANSDUCTION VIA THE CD4 MOLECULE
通过 CD4 分子进行信号转导
  • 批准号:
    3455197
  • 财政年份:
    1989
  • 资助金额:
    $ 28.26万
  • 项目类别:
SIGNAL TRANSDUCTION VIA THE CD4 MOLECULE
通过 CD4 分子进行信号转导
  • 批准号:
    3455196
  • 财政年份:
    1989
  • 资助金额:
    $ 28.26万
  • 项目类别:
MOUSE MONOCLONAL ANTIBODIES AGAINST HUMAN CD4 MOLECULE GENERATE MONOCLONAL ANT
抗人 CD4 分子的小鼠单克隆抗体生成单克隆蚂蚁
  • 批准号:
    3810218
  • 财政年份:
  • 资助金额:
    $ 28.26万
  • 项目类别:
MOUSE MONOCLONAL ANTIBODIES AGAINST HUMAN CD4 MOLECULE
针对人 CD4 分子的小鼠单克隆抗体
  • 批准号:
    3803662
  • 财政年份:
  • 资助金额:
    $ 28.26万
  • 项目类别:
MOUSE MONOCLONAL ANTIBODIES AGAINST HUMAN CD4 MOLECULE GENERATE MONOCLONAL ANT
抗人 CD4 分子的小鼠单克隆抗体生成单克隆蚂蚁
  • 批准号:
    3814788
  • 财政年份:
  • 资助金额:
    $ 28.26万
  • 项目类别:
MOUSE MONOCLONAL ANTIBODIES AGAINST HUMAN CD4 MOLECULE GENERATE MONOCLONAL ANT
抗人 CD4 分子的小鼠单克隆抗体生成单克隆蚂蚁
  • 批准号:
    3818867
  • 财政年份:
  • 资助金额:
    $ 28.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了